Key points are not available for this paper at this time.
The four-miRNA signature from the serum may serve as a noninvasive predictor for the overall survival of NSCLC.
Hu et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: